These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32496874)

  • 1. Evaluating the Impact of Oncology Care Model Reporting Requirements on Biomarker Testing and Treatment.
    Castellanos EH; Orlando A; Ma X; Parikh RB; O'Connell G; Meropol NJ; Hamrick J; Adamson BJS
    JCO Oncol Pract; 2020 Oct; 16(10):e1216-e1221. PubMed ID: 32496874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Oncologist Participation in Medicare's Oncology Care Model With Patient Receipt of Novel Cancer Therapies.
    Manz CR; Tramontano AC; Uno H; Parikh RB; Bekelman JE; Schrag D
    JAMA Netw Open; 2022 Sep; 5(9):e2234161. PubMed ID: 36173630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of Physicians Participating in Medicare's Oncology Care Model Bundled Payment Program.
    Parikh RB; Bekelman JE; Huang Q; Martinez JR; Emanuel EJ; Navathe AS
    J Oncol Pract; 2019 Oct; 15(10):e897-e905. PubMed ID: 31393806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving biomarker testing in advanced non-small-cell lung cancer and metastatic colorectal cancer: experience from a large community oncology network in the USA.
    Schwartzberg L; Daniel D; Vaena D; Slater D; Staszewski H; Fang B; Seneviratne L; Yu E; Price R; Szado T; Meyer CS; Shah A; Ma E
    Future Oncol; 2023 Jun; 19(20):1397-1414. PubMed ID: 37318757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations Between Medicaid Insurance, Biomarker Testing, and Outcomes in Patients With Advanced NSCLC.
    Gross CP; Meyer CS; Ogale S; Kent M; Wong WB
    J Natl Compr Canc Netw; 2022 May; 20(5):479-487.e2. PubMed ID: 35545174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Participation in Medicare's Oncology Care Model With Spending, Utilization, and Quality Outcomes Among Commercially Insured and Medicare Advantage Members.
    Mullangi S; Ukert B; Devries A; Debono D; Santos J; Fisch MJ; Schleicher SM; Navathe AS; Bekelman JE; Schwartz AL; Parikh RB
    J Clin Oncol; 2024 Oct; ():JCO2400502. PubMed ID: 39356984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Medicare's National Coverage Determination and Utilization of Next-Generation Sequencing.
    Sheinson DM; Wong WB; Flores C; Ogale S; Gross CP
    JCO Oncol Pract; 2021 Nov; 17(11):e1774-e1784. PubMed ID: 34043456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Provider Practice Competition and Adoption of Medicare's Oncology Care Model.
    Jalali A; Martin C; Nelson RE; Vanneman ME; Martin BI; Cooney KA; Waitzman NJ; O'Neil B
    Med Care; 2020 Feb; 58(2):154-160. PubMed ID: 31688568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-World Impact of Comprehensive Genomic Profiling on Biomarker Detection, Receipt of Therapy, and Clinical Outcomes in Advanced Non-Small Cell Lung Cancer.
    Wallenta Law J; Bapat B; Sweetnam C; Mohammed H; McBratney A; Izano MA; Scannell Bryan M; Spencer S; Schroeder B; Hostin D; Simon GR; Berry AB
    JCO Precis Oncol; 2024 May; 8():e2400075. PubMed ID: 38754057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining comprehensive biomarker-related testing and treatment practices for advanced non-small-cell lung cancer: Results of a survey of U.S. oncologists.
    Mileham KF; Schenkel C; Bruinooge SS; Freeman-Daily J; Basu Roy U; Moore A; Smith RA; Garrett-Mayer E; Rosenthal L; Garon EB; Johnson BE; Osarogiagbon RU; Jalal S; Virani S; Weber Redman M; Silvestri GA
    Cancer Med; 2022 Jan; 11(2):530-538. PubMed ID: 34921524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health care resource utilization, quality metrics, and costs of bladder cancer within the Oncology Care Model.
    Wirtz HS; Hepp Z; Grewal S; Wright P; Fuldeore R; Tomicki S; Hirsch J; Dieguez G; Blakely LJ
    Am J Manag Care; 2023 May; 29(5):e136-e142. PubMed ID: 37229787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the Oncology Care Model on Use of Supportive Care Medications During Cancer Treatment.
    Brooks GA; Landrum MB; Kapadia NS; Liu PH; Wolf R; Riedel LE; Hsu VD; Jhatakia Parekh S; Simon C; Hassol A; Keating NL
    J Clin Oncol; 2022 Jun; 40(16):1763-1771. PubMed ID: 35213212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Reflex EGFR/ ALK Testing on Time to Treatment of Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer.
    Cheema PK; Menjak IB; Winterton-Perks Z; Raphael S; Cheng SY; Verma S; Muinuddin A; Freedman R; Toor N; Perera J; Anaka M; Victor JC
    J Oncol Pract; 2017 Feb; 13(2):e130-e138. PubMed ID: 28029301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the Oncology Care Model With Value-Based Changes in Use of Radiation Therapy.
    Kapadia NS; Brooks GA; Landrum MB; Riedel L; Liu PH; Hassol A; Tripp AS; Jhatakia S; Kummet CM; Keating NL
    Int J Radiat Oncol Biol Phys; 2022 Sep; 114(1):39-46. PubMed ID: 35150787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Clinical Practice Gaps on the Implementation of Personalized Medicine in Advanced Non-Small-Cell Lung Cancer.
    Sadik H; Pritchard D; Keeling DM; Policht F; Riccelli P; Stone G; Finkel K; Schreier J; Munksted S
    JCO Precis Oncol; 2022 Oct; 6():e2200246. PubMed ID: 36315914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Findings From the Oncology Care Model Evaluation.
    Brooks GA; Jhatakia S; Tripp A; Landrum MB; Christian TJ; Newes-Adeyi G; Cafardi S; Hassol A; Simon C; Keating NL
    J Oncol Pract; 2019 Oct; 15(10):e888-e896. PubMed ID: 31393807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the Experiences of Patients in the Oncology Care Model.
    Franklin EF; Nichols HM; Bohannon L
    JCO Oncol Pract; 2020 Dec; 16(12):e1433-e1440. PubMed ID: 33026952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practice patterns among oncologists participating in the oncology care model after three years.
    Walker B; Wilfong L; Frytak J; Robert N
    J Cancer Policy; 2021 Sep; 29():100294. PubMed ID: 35559949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Oncology Care Model: Perspectives From the Centers for Medicare & Medicaid Services and Participating Oncology Practices in Academia and the Community.
    Kline R; Adelson K; Kirshner JJ; Strawbridge LM; Devita M; Sinanis N; Conway PH; Basch E
    Am Soc Clin Oncol Educ Book; 2017; 37():460-466. PubMed ID: 28561660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Share of Oncology Versus Nononcology Spending in Episodes Defined by the Centers for Medicare & Medicaid Services Oncology Care Model.
    Baumgardner JR; Shahabi A; Linthicum MT; Zacker C; Lakdawalla DN
    J Oncol Pract; 2018 Nov; 14(11):e699-e710. PubMed ID: 30423271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.